Missouri 2026 Regular Session

Missouri House Bill HB2642

Introduced
1/7/26  
Refer
1/20/26  
Report Pass
1/29/26  
Refer
2/9/26  
Report Pass
2/17/26  
Engrossed
3/16/26  
Engrossed
3/19/26  

Caption

Creates provisions relating to insurance coverage of alternatives to opioid drugs

Impact

The implementation of HB 2642 is expected to impact state laws by modifying existing regulations surrounding health benefit plans. By prohibiting insurance providers from favoring opioid prescriptions over nonopioid alternatives, the bill seeks to shift the paradigm of pain management in Missouri. This shift is particularly significant as it aligns with growing public health initiatives aimed at reducing dependency on opioids and mitigating the associated risks of addiction and overdose.

Summary

House Bill 2642 aims to establish new provisions related to insurance coverage for alternatives to opioid drugs. Specifically, it mandates that health benefit plans cannot deny coverage for nonopioid medications prescribed for the treatment of acute or chronic pain. This legislation reflects an ongoing effort to address the opioid crisis by incentivizing the use of nonopioid pain management options, helping both healthcare providers and patients gain access to safer alternatives.

Sentiment

Discussions around HB 2642 have been predominantly positive among healthcare professionals and advocates for public health reform. Many see it as a necessary step in the evolution of pain management standards. However, there are some concerns regarding the readiness of healthcare providers to effectively transition to prescribing nonopioid alternatives and whether insurers will comply fully with the new requirements as outlined in the bill.

Contention

Notable points of contention surrounding the bill include concerns from some lawmakers and insurance stakeholders about the cost implications of mandated coverage for nonopioid alternatives. Critics have raised questions about the scienific support behind certain nonopioid treatments and their potential efficacy compared to traditional opioid therapies. Despite these discussions, proponents of the bill argue that the long-term benefits of reducing opioid prescriptions will outweigh initial obstacles in implementation.

Companion Bills

No companion bills found.

Previously Filed As

MO SB158

Enacts provisions relating to insurance coverage of alternatives to opioid drugs

MO HB804

Enacts provisions relating to insurance coverage of alternatives to opioid drugs

MO SB175

Enacts provisions relating to insurance coverage for prescription insulin drugs

MO SB13

Enacts provisions relating to insurance coverage of pharmacy services

MO SB260

Enacts provisions relating to health insurance coverage of maternity services

MO HB877

Creates provisions relating to insurance coverage of drugs

MO SB308

Enacts provisions relating to insurance coverage for cancer treatment

MO SB550

Enacts provisions relating to insurance coverage for mental health treatments

MO SB567

Enacts provisions relating to insurance coverage for mental health treatments

MO SB406

Enacts provisions relating to insurance coverage of genetic screenings for cancer risk

Similar Bills

No similar bills found.